Inovio Pharmaceuticals, Inc. · NASDAQ:INO
Kies Peter exercised options for 8,700 Inovio Pharmaceuticals, Inc. shares (Form 4)
Traded May 20, 2026 · Filed May 21, 2026
On May 20, 2026, Kies Peter (CFO) exercised options for 8,700 Inovio Pharmaceuticals, Inc. shares, leaving 42,854 shares. Filed May 21, 2026 (Form 4).
- Options exercised
- 8,700 shares
- Holding after
- 42,854 shares
- Trading plan
- No
- Role
- CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | Option exercise | 8,700 | 47,542 | Direct | |
| May 20, 2026 | Common Stock | Shares withheld for tax | 4,688 | US$1.23 | 42,854 | Direct |
Source
Related
- Inovio Pharmaceuticals, Inc.
- Kies Peter
- Inovio Pharmaceuticals, Inc. shareholders
- Form 4 · Kies Peter · May 18, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Humeau Laurent · May 21, 2026